Oxford Asset Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-470,283
| Closed | -$21.8M | – | 2105 |
|
|
2019
Q2 | $21.8M | Buy |
+470,283
| New | +$13.2M | 0.47% | 16 |
|
|
2018
Q3 | – | Sell |
-212,898
| Closed | -$3.55M | – | 2072 |
|
|
2018
Q2 | $3.55M | Buy |
212,898
+16,144
| +8% | +$257K | 0.07% | 336 |
|
|
2018
Q1 | $3.21M | Buy |
+196,754
| New | +$3.15M | 0.07% | 334 |
|
|
2017
Q4 | – | Sell |
-20,731
| Closed | -$256K | – | 1981 |
|
|
2017
Q3 | $256K | Sell |
20,731
-126,379
| -86% | -$1.17M | ﹤0.01% | 1373 |
|
|
2017
Q2 | $1.23M | Sell |
147,110
-56,520
| -28% | -$462K | 0.02% | 816 |
|
|
2017
Q1 | $1.82M | Buy |
+203,630
| New | +$2.17M | 0.04% | 533 |
|
|
2016
Q1 | – | Sell |
-1,064,085
| Closed | -$4.46M | – | 966 |
|
|
2015
Q4 | $4.46M | Buy |
+1,064,085
| New | +$4.86M | 0.11% | 209 |
|
|
2014
Q3 | – | Sell |
-31,743
| Closed | -$136K | – | 797 |
|
|
2014
Q2 | $136K | Buy |
+31,743
| New | +$131K | ﹤0.01% | 650 |
|
|
2014
Q1 | – | Sell |
-52,163
| Closed | -$261K | – | 820 |
|
|
2013
Q4 | $261K | Sell |
52,163
-250,955
| -83% | -$1.37M | 0.01% | 634 |
|
|
2013
Q3 | $1.89M | Sell |
303,118
-233,528
| -44% | -$1.39M | 0.04% | 472 |
|
|
2013
Q2 | $2.44M | Buy |
+536,646
| New | +$2.89M | 0.07% | 424 |
|
Other funds holding ARRY
Oxford Asset Management's ARRY Position: Q3 2019 in Review
Oxford Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 470,283 shares — an estimated $21.8M sold.
Oxford Asset Management first reported a position in ARRY in Q2 2013 and held it in 11 quarters. The position peaked at $21.8M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Oxford Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Oxford Asset Management sold 470,283 Array Biopharma Inc shares in Q3 2019, an estimated $21.8M.
- Oxford Asset Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 11 quarters.
- Oxford Asset Management's Array Biopharma Inc position peaked at $21.8M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.